Table 3: Percentage of CD4+/CD25+, CD4+/CD28+ lymphocytes, and CD80+ cells of CD14+ population, in PHA-cultures with (a) E. coli LPS and (b) HKBA (results are presented as mean  ±  SD). NS: nonsignificant.

(a) E. coli LPS culturesn %CD4+/CD25+ %CD4+/CD28+ %CD14+/CD80+

AB 13
CB 22
Cured 11
Controls 15

P (AB versus cured)  =  NSP (AB versus cured)  =  NSP(AB versus cured)  =  .002
P (AB versus controls)  =  .027P (AB versus controls)  =  NSP (AB versus controls)  <  .001
P (CB versus cured)  =  NSP (CB versus cured)  =  NSP (CB versus cured)  =  .001
P (CB versus controls)  =  NSP (CB versus controls)  =  NSP (CB versus controls)  <  .001
P (AB versus CB)  =  .006P (AB versus CB)  =  .024P (AB versus CB)  =  NS

CB1 12
CB2 10

P (CB1 versus AB)  =  .008P (CB1 versus AB)  =  .039P (CB1 versus CB2)  =  NS
P (CB1 versus controls)  =  .003
P (CB2 versus controls)  =  .004

(b)HKBA cultures

AB 13
CB 22
Cured 11
Controls 15

NSNSP (AB versus controls)  =  .047
P (CB versus controls)  =  .004

CB1 12
CB2 10

NSNSP (CB1 versus CB2)  =  .038
P (CB1 versus cured)  =  .012
P (CB1 versus controls)  =  .003